Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.
Press releases published on October 18, 2025

CV5 CAPITAL BRIDGES INSTITUTIONAL STANDARDS AND DIGITAL INNOVATION FOR FUND MANAGERS
CV5 Capital, a Cayman Islands-based institutional fund platform regulated by CIMA is helping fund managers launch both traditional hedge funds and crypto funds. GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS, October 18, 2025 /EINPresswire.com/ -- GRAND …

First Class Label Group Announces Partnership with Warner Music Group for the Release of Lara Trump EP
A global collaboration bringing together artistry, influence, and innovation for a new era in music and media. NEW YORK CITY, NY, UNITED STATES, October 18, 2025 /EINPresswire.com/ -- First Class Label Group (FCLG) proudly announces a global partnership …

American Management University (Paris, France) Gains Recognition for MBA program from the Chartered Management Institute
Recognition from the UK’s Chartered Management Institute affirms AMU’s commitment to professional standards for middle- and senior-management development. PARIS, FRANCE, October 17, 2025 /EINPresswire.com/ -- American Management University (AMU), a …

DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
Dubai, UAE , Oct. 18, 2025 (GLOBE NEWSWIRE) -- The DeFi market continues to evolve rapidly, and new protocols are emerging that aim to push the industry forward in both utility and adoption. One project gaining major attention is Mutuum Finance (MUTM), a …

ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus across patient subgroups Berlin, Germany, October 18, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, …